SEC Form 4 · accession 0000899243-17-019998
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence E Bullock
Officer — Chief Financial Officer
Period of report
Aug 3, 2017
Accepted (ET)
Aug 9, 2017 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.50 | Aug 3, 2017 | A | 4,168 | A | — | Aug 3, 2027 | Common Stock | 4,168 | 4,168 | D |
Explanation of responses
- F1Option became exercisable for 25% on August 3, 2017, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments on the last day of each calendar month beginning August 31, 2017 and ending October 31, 2017, as long as Mr. Bullock continues to be employed with Applied Genetic Technologies Corporation and with no further vesting after his employment ends.